25 XP   0   0   10

Laurus Labs Ltd
Buy, Hold or Sell?

Let's analyse Laurus Labs Ltd together

PenkeI guess you are interested in Laurus Labs Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Laurus Labs Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Laurus Labs Ltd

I send you an email if I find something interesting about Laurus Labs Ltd.

Quick analysis of Laurus Labs Ltd (30 sec.)










What can you expect buying and holding a share of Laurus Labs Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.10
When do you have the money?
1 year
How often do you get paid?
87.5%

What is your share worth?

Current worth
INR74.91
Expected worth in 1 year
INR125.85
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR58.91
Return On Investment
15.0%

For what price can you sell your share?

Current Price per Share
INR391.75
Expected price per share
INR358.70 - INR441.82
How sure are you?
50%

1. Valuation of Laurus Labs Ltd (5 min.)




Live pricePrice per Share (EOD)

INR391.75

Intrinsic Value Per Share

INR-24.03 - INR16.65

Total Value Per Share

INR50.88 - INR91.56

2. Growth of Laurus Labs Ltd (5 min.)




Is Laurus Labs Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$484.5m$402.1m$82.3m17.0%

How much money is Laurus Labs Ltd making?

Current yearPrevious yearGrowGrow %
Making money$94.8m$99.3m-$4.4m-4.7%
Net Profit Margin13.1%16.8%--

How much money comes from the company's main activities?

3. Financial Health of Laurus Labs Ltd (5 min.)




What can you expect buying and holding a share of Laurus Labs Ltd? (5 min.)

Welcome investor! Laurus Labs Ltd's management wants to use your money to grow the business. In return you get a share of Laurus Labs Ltd.

What can you expect buying and holding a share of Laurus Labs Ltd?

First you should know what it really means to hold a share of Laurus Labs Ltd. And how you can make/lose money.

Speculation

The Price per Share of Laurus Labs Ltd is INR391.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Laurus Labs Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Laurus Labs Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR74.91. Based on the TTM, the Book Value Change Per Share is INR12.73 per quarter. Based on the YOY, the Book Value Change Per Share is INR13.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.99 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Laurus Labs Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.180.0%0.180.0%0.180.0%0.130.0%0.100.0%
Usd Book Value Change Per Share0.150.0%0.150.0%0.170.0%0.110.0%0.110.0%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.180.0%0.180.0%0.190.0%0.130.0%0.120.0%
Usd Price Per Share4.50-4.50-6.47-4.82-4.54-
Price to Earnings Ratio25.59-25.59-35.12-74.85-85.78-
Price-to-Total Gains Ratio25.47-25.47-34.62-76.81-87.45-
Price to Book Ratio5.01-5.01-8.67-9.02-10.53-
Price-to-Total Gains Ratio25.47-25.47-34.62-76.81-87.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.701
Number of shares212
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.150.11
Usd Total Gains Per Share0.180.13
Gains per Quarter (212 shares)37.4727.10
Gains per Year (212 shares)149.88108.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
120130140129698
24125929024193206
36138944036289314
48151859048386422
510164874060482530
612277889072579638
7142907104084675746
81621037119096772854
918311661340107868962
10203129614901199651070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.01.087.5%7.00.01.087.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%

Fundamentals of Laurus Labs Ltd

About Laurus Labs Ltd

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-03-23 13:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Laurus Labs Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Laurus Labs Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.1% means that ₹0.13 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Laurus Labs Ltd:

  • The MRQ is 13.1%. The company is making a huge profit. +2
  • The TTM is 13.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.1%TTM13.1%0.0%
TTM13.1%YOY16.8%-3.7%
TTM13.1%5Y12.7%+0.4%
5Y12.7%10Y11.1%+1.6%
1.1.2. Return on Assets

Shows how efficient Laurus Labs Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.3% Return on Assets means that Laurus Labs Ltd generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Laurus Labs Ltd:

  • The MRQ is 10.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY11.9%-1.6%
TTM10.3%5Y9.8%+0.5%
5Y9.8%10Y8.5%+1.3%
1.1.3. Return on Equity

Shows how efficient Laurus Labs Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 19.6% Return on Equity means Laurus Labs Ltd generated ₹0.20 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Laurus Labs Ltd:

  • The MRQ is 19.6%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.6%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.6%TTM19.6%0.0%
TTM19.6%YOY24.7%-5.1%
TTM19.6%5Y20.5%-0.9%
5Y20.5%10Y18.0%+2.5%

1.2. Operating Efficiency of Laurus Labs Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Laurus Labs Ltd is operating .

  • Measures how much profit Laurus Labs Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 21.1% means the company generated ₹0.21  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Laurus Labs Ltd:

  • The MRQ is 21.1%. The company is operating efficient. +1
  • The TTM is 21.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.1%TTM21.1%0.0%
TTM21.1%YOY23.8%-2.7%
TTM21.1%5Y19.2%+1.9%
5Y19.2%10Y15.8%+3.4%
1.2.2. Operating Ratio

Measures how efficient Laurus Labs Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ₹1.31 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Laurus Labs Ltd:

  • The MRQ is 1.314. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.314. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.314TTM1.3140.000
TTM1.314YOY1.250+0.064
TTM1.3145Y1.323-0.009
5Y1.32310Y1.252+0.071

1.3. Liquidity of Laurus Labs Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Laurus Labs Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.42 means the company has ₹1.42 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Laurus Labs Ltd:

  • The MRQ is 1.423. The company is just able to pay all its short-term debts.
  • The TTM is 1.423. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.423TTM1.4230.000
TTM1.423YOY1.248+0.176
TTM1.4235Y1.204+0.219
5Y1.20410Y1.141+0.063
1.3.2. Quick Ratio

Measures if Laurus Labs Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ₹0.67 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Laurus Labs Ltd:

  • The MRQ is 0.671. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.671. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.671TTM0.6710.000
TTM0.671YOY0.534+0.137
TTM0.6715Y0.551+0.120
5Y0.55110Y0.533+0.018

1.4. Solvency of Laurus Labs Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Laurus Labs Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Laurus Labs Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Laurus Labs Ltd assets are financed with 47.3% credit (debt) and the remaining percentage (100% - 47.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Laurus Labs Ltd:

  • The MRQ is 0.473. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.473. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.473TTM0.4730.000
TTM0.473YOY0.519-0.046
TTM0.4735Y0.520-0.047
5Y0.52010Y0.528-0.008
1.4.2. Debt to Equity Ratio

Measures if Laurus Labs Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 89.7% means that company has ₹0.90 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Laurus Labs Ltd:

  • The MRQ is 0.897. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.897. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.897TTM0.8970.000
TTM0.897YOY1.079-0.182
TTM0.8975Y1.089-0.192
5Y1.08910Y1.134-0.044

2. Market Valuation of Laurus Labs Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Laurus Labs Ltd generates.

  • Above 15 is considered overpriced but always compare Laurus Labs Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 25.59 means the investor is paying ₹25.59 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Laurus Labs Ltd:

  • The EOD is 26.723. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.591. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.591. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD26.723MRQ25.591+1.132
MRQ25.591TTM25.5910.000
TTM25.591YOY35.118-9.528
TTM25.5915Y74.846-49.255
5Y74.84610Y85.779-10.933
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Laurus Labs Ltd:

  • The EOD is 5,645.453. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 5,406.233. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 5,406.233. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5,645.453MRQ5,406.233+239.220
MRQ5,406.233TTM5,406.2330.000
TTM5,406.233YOY848.250+4,557.983
TTM5,406.2335Y1,462.217+3,944.016
5Y1,462.21710Y897.969+564.248
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Laurus Labs Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.01 means the investor is paying ₹5.01 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Laurus Labs Ltd:

  • The EOD is 5.229. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.008. Based on the equity, the company is overpriced. -1
  • The TTM is 5.008. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.229MRQ5.008+0.222
MRQ5.008TTM5.0080.000
TTM5.008YOY8.672-3.664
TTM5.0085Y9.018-4.010
5Y9.01810Y10.532-1.514
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Laurus Labs Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.73412.7340%13.983-9%9.481+34%9.364+36%
Book Value Per Share--74.91374.9130%62.178+20%49.407+52%39.391+90%
Current Ratio--1.4231.4230%1.248+14%1.204+18%1.141+25%
Debt To Asset Ratio--0.4730.4730%0.519-9%0.520-9%0.528-10%
Debt To Equity Ratio--0.8970.8970%1.079-17%1.089-18%1.134-21%
Dividend Per Share--1.9941.9940%1.593+25%1.174+70%0.782+155%
Eps--14.66014.6600%15.354-5%10.948+34%7.978+84%
Free Cash Flow Per Share--0.0690.0690%0.636-89%0.931-93%0.259-73%
Free Cash Flow To Equity Per Share---0.425-0.4250%1.197-135%1.250-134%0.672-163%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16.652--------
Intrinsic Value_10Y_min---24.029--------
Intrinsic Value_1Y_max--1.092--------
Intrinsic Value_1Y_min---0.229--------
Intrinsic Value_3Y_max--3.721--------
Intrinsic Value_3Y_min---2.579--------
Intrinsic Value_5Y_max--6.880--------
Intrinsic Value_5Y_min---6.984--------
Market Cap211139936768.000+4%202193100902.400202193100902.4000%290610475827.200-30%216314010521.600-7%204089587571.200-1%
Net Profit Margin--0.1310.1310%0.168-22%0.127+3%0.111+18%
Operating Margin--0.2110.2110%0.238-11%0.192+10%0.158+34%
Operating Ratio--1.3141.3140%1.250+5%1.323-1%1.252+5%
Pb Ratio5.229+4%5.0085.0080%8.672-42%9.018-44%10.532-52%
Pe Ratio26.723+4%25.59125.5910%35.118-27%74.846-66%85.779-70%
Price Per Share391.750+4%375.150375.1500%539.200-30%401.350-7%378.669-1%
Price To Free Cash Flow Ratio5645.453+4%5406.2335406.2330%848.250+537%1462.217+270%897.969+502%
Price To Total Gains Ratio26.598+4%25.47125.4710%34.617-26%76.807-67%87.453-71%
Quick Ratio--0.6710.6710%0.534+26%0.551+22%0.533+26%
Return On Assets--0.1030.1030%0.119-13%0.098+5%0.085+22%
Return On Equity--0.1960.1960%0.247-21%0.205-5%0.180+9%
Total Gains Per Share--14.72814.7280%15.576-5%10.654+38%10.146+45%
Usd Book Value--484503600.000484503600.0000%402142800.000+20%319546920.000+52%254765100.000+90%
Usd Book Value Change Per Share--0.1530.1530%0.168-9%0.114+34%0.112+36%
Usd Book Value Per Share--0.8990.8990%0.746+20%0.593+52%0.473+90%
Usd Dividend Per Share--0.0240.0240%0.019+25%0.014+70%0.009+155%
Usd Eps--0.1760.1760%0.184-5%0.131+34%0.096+84%
Usd Free Cash Flow--448800.000448800.0000%4111200.000-89%6020592.000-93%1678320.000-73%
Usd Free Cash Flow Per Share--0.0010.0010%0.008-89%0.011-93%0.003-73%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%0.014-135%0.015-134%0.008-163%
Usd Market Cap2533679241.216+4%2426317210.8292426317210.8290%3487325709.926-30%2595768126.259-7%2449075050.854-1%
Usd Price Per Share4.701+4%4.5024.5020%6.470-30%4.816-7%4.544-1%
Usd Profit--94813200.00094813200.0000%99302400.000-5%70805928.000+34%51628020.000+84%
Usd Revenue--724866000.000724866000.0000%592268400.000+22%501918456.000+44%400872105.000+81%
Usd Total Gains Per Share--0.1770.1770%0.187-5%0.128+38%0.122+45%
 EOD+4 -4MRQTTM+0 -0YOY+13 -225Y+24 -1110Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Laurus Labs Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.723
Price to Book Ratio (EOD)Between0-15.229
Net Profit Margin (MRQ)Greater than00.131
Operating Margin (MRQ)Greater than00.211
Quick Ratio (MRQ)Greater than10.671
Current Ratio (MRQ)Greater than11.423
Debt to Asset Ratio (MRQ)Less than10.473
Debt to Equity Ratio (MRQ)Less than10.897
Return on Equity (MRQ)Greater than0.150.196
Return on Assets (MRQ)Greater than0.050.103
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Laurus Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.329
Ma 20Greater thanMa 50402.063
Ma 50Greater thanMa 100398.263
Ma 100Greater thanMa 200396.302
OpenGreater thanClose392.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets76,604,000
Total Liabilities36,228,700
Total Stockholder Equity40,375,300
 As reported
Total Liabilities 36,228,700
Total Stockholder Equity+ 40,375,300
Total Assets = 76,604,000

Assets

Total Assets76,604,000
Total Current Assets34,616,800
Long-term Assets41,987,200
Total Current Assets
Cash And Cash Equivalents 193,400
Short-term Investments 25,100
Net Receivables 15,804,400
Inventory 16,848,100
Other Current Assets 1,470,000
Total Current Assets  (as reported)34,616,800
Total Current Assets  (calculated)34,341,000
+/- 275,800
Long-term Assets
Property Plant Equipment 37,001,700
Goodwill 2,463,000
Intangible Assets 129,300
Other Assets 1,894,200
Long-term Assets  (as reported)41,987,200
Long-term Assets  (calculated)41,488,200
+/- 499,000

Liabilities & Shareholders' Equity

Total Current Liabilities24,322,600
Long-term Liabilities11,794,800
Total Stockholder Equity40,375,300
Total Current Liabilities
Short-term Debt 9,957,700
Short Long Term Debt 12,105,500
Accounts payable 7,106,500
Other Current Liabilities 5,053,800
Total Current Liabilities  (as reported)24,322,600
Total Current Liabilities  (calculated)34,223,500
+/- 9,900,900
Long-term Liabilities
Long term Debt Total 7,988,600
Other Liabilities 3,806,200
Long-term Liabilities  (as reported)11,794,800
Long-term Liabilities  (calculated)11,794,800
+/-0
Total Stockholder Equity
Common Stock1,077,300
Retained Earnings 32,206,000
Capital Surplus 7,130,600
Total Stockholder Equity (as reported)40,375,300
Total Stockholder Equity (calculated)40,413,900
+/- 38,600
Other
Capital Stock1,077,300
Cash And Equivalents266,100
Cash and Short Term Investments 484,600
Common Stock Shares Outstanding 538,651
Liabilities and Stockholders Equity 76,604,000
Net Debt 19,263,000
Net Invested Capital 60,095,000
Net Tangible Assets 37,783,000
Net Working Capital 10,294,200
Property Plant and Equipment Gross 37,001,700



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
22,235,240
26,534,200
30,167,200
33,311,850
37,503,160
57,506,900
69,680,400
76,604,000
76,604,00069,680,40057,506,90037,503,16033,311,85030,167,20026,534,20022,235,240
   > Total Current Assets 
10,027,330
11,398,190
12,475,910
14,629,580
18,120,600
30,748,600
33,446,100
34,616,800
34,616,80033,446,10030,748,60018,120,60014,629,58012,475,91011,398,19010,027,330
       Cash And Cash Equivalents 
160,170
2,570
3,590
470
16,880
484,600
539,300
193,400
193,400539,300484,60016,8804703,5902,570160,170
       Short-term Investments 
0
16,680
530
530
520
390,700
3,600
25,100
25,1003,600390,70052053053016,6800
       Net Receivables 
4,448,570
5,941,380
5,919,280
7,313,320
7,914,200
13,060,600
13,541,800
15,804,400
15,804,40013,541,80013,060,6007,914,2007,313,3205,919,2805,941,3804,448,570
       Inventory 
4,870,930
5,090,460
5,847,820
6,819,370
9,052,200
15,754,500
17,603,000
16,848,100
16,848,10017,603,00015,754,5009,052,2006,819,3705,847,8205,090,4604,870,930
       Other Current Assets 
475,490
250,070
580,320
349,450
621,700
887,900
1,367,700
1,470,000
1,470,0001,367,700887,900621,700349,450580,320250,070475,490
   > Long-term Assets 
0
15,136,010
17,691,290
18,682,270
19,382,610
26,758,300
36,234,300
41,987,200
41,987,20036,234,30026,758,30019,382,61018,682,27017,691,29015,136,0100
       Property Plant Equipment 
10,842,390
13,555,990
16,270,780
17,168,310
17,740,240
22,771,700
32,085,600
37,001,700
37,001,70032,085,60022,771,70017,740,24017,168,31016,270,78013,555,99010,842,390
       Goodwill 
0
97,390
97,390
97,390
97,390
2,463,000
2,463,000
2,463,000
2,463,0002,463,0002,463,00097,39097,39097,39097,3900
       Intangible Assets 
63,880
78,530
71,580
121,310
97,530
93,200
108,300
129,300
129,300108,30093,20097,530121,31071,58078,53063,880
       Long-term Assets Other 
0
20,000
20,000
20,000
0
958,900
598,900
1,195,700
1,195,700598,900958,900020,00020,00020,0000
> Total Liabilities 
13,667,260
13,229,720
15,340,810
17,727,780
19,805,380
31,531,400
36,168,500
36,228,700
36,228,70036,168,50031,531,40019,805,38017,727,78015,340,81013,229,72013,667,260
   > Total Current Liabilities 
8,837,480
11,207,500
13,068,860
14,239,040
16,923,800
24,571,500
26,810,100
24,322,600
24,322,60026,810,10024,571,50016,923,80014,239,04013,068,86011,207,5008,837,480
       Short-term Debt 
4,814,190
6,441,710
7,585,170
6,842,050
7,905,130
8,861,200
9,107,200
9,957,700
9,957,7009,107,2008,861,2007,905,1306,842,0507,585,1706,441,7104,814,190
       Short Long Term Debt 
0
7,171,850
8,382,480
7,772,160
8,918,540
11,222,500
11,356,900
12,105,500
12,105,50011,356,90011,222,5008,918,5407,772,1608,382,4807,171,8500
       Accounts payable 
0
2,630,990
3,123,270
4,883,120
6,156,300
11,786,900
8,763,700
7,106,500
7,106,5008,763,70011,786,9006,156,3004,883,1203,123,2702,630,9900
       Other Current Liabilities 
0
1,220,790
1,396,960
1,420,760
1,626,000
2,251,200
6,272,800
5,053,800
5,053,8006,272,8002,251,2001,626,0001,420,7601,396,9601,220,7900
   > Long-term Liabilities 
0
1,968,060
2,271,950
3,488,740
2,881,720
6,928,400
9,279,800
11,794,800
11,794,8009,279,8006,928,4002,881,7203,488,7402,271,9501,968,0600
       Long term Debt Total 
4,597,400
1,245,620
1,416,590
2,587,130
1,855,810
4,554,300
6,359,700
7,988,600
7,988,6006,359,7004,554,3001,855,8102,587,1301,416,5901,245,6204,597,400
       Other Liabilities 
0
776,600
855,360
901,610
1,025,900
2,374,100
2,920,100
3,806,200
3,806,2002,920,1002,374,1001,025,900901,610855,360776,6000
> Total Stockholder Equity
8,567,980
13,304,480
14,826,390
15,584,070
17,697,780
25,975,500
33,511,900
40,375,300
40,375,30033,511,90025,975,50017,697,78015,584,07014,826,39013,304,4808,567,980
   Common Stock
823,800
1,057,560
1,060,300
1,064,370
1,069,100
1,073,200
1,074,700
1,077,300
1,077,3001,074,7001,073,2001,069,1001,064,3701,060,3001,057,560823,800
   Retained Earnings 
3,641,780
5,460,300
6,965,310
7,711,220
9,875,900
18,832,900
26,249,500
32,206,000
32,206,00026,249,50018,832,9009,875,9007,711,2206,965,3105,460,3003,641,780
   Capital Surplus 
4,070,930
6,703,540
6,737,320
6,786,640
6,852,020
6,947,700
7,013,200
7,130,600
7,130,6007,013,2006,947,7006,852,0206,786,6406,737,3206,703,5404,070,930
   Treasury Stock00000000
   Other Stockholders Equity 
4,890
83,080
63,460
21,840
-99,300
-878,300
-825,500
39,298,000
39,298,000-825,500-878,300-99,30021,84063,46083,0804,890



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue53,056,300
Cost of Revenue-26,453,500
Gross Profit26,602,80026,602,800
 
Operating Income (+$)
Gross Profit26,602,800
Operating Expense-45,906,400
Operating Income7,149,900-19,303,600
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense45,906,4000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,351,100
Other Finance Cost-151,400
Net Interest Income-1,502,500
 
Pretax Income (+$)
Operating Income7,149,900
Net Interest Income-1,502,500
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,194,6007,149,900
EBIT - interestExpense = -1,351,100
3,678,200
5,029,300
Interest Expense1,351,100
Earnings Before Interest and Taxes (EBIT)-6,545,700
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax5,194,600
Tax Provision-1,414,400
Net Income From Continuing Ops3,717,2003,780,200
Net Income3,678,200
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,502,500
 

Technical Analysis of Laurus Labs Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Laurus Labs Ltd. The general trend of Laurus Labs Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Laurus Labs Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Laurus Labs Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 426.30 < 441.32 < 441.82.

The bearish price targets are: 372.20 > 359.10 > 358.70.

Tweet this
Laurus Labs Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Laurus Labs Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Laurus Labs Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Laurus Labs Ltd. The current macd is -2.93720701.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Laurus Labs Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Laurus Labs Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Laurus Labs Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Laurus Labs Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLaurus Labs Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Laurus Labs Ltd. The current adx is 17.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Laurus Labs Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Laurus Labs Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Laurus Labs Ltd. The current sar is 405.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Laurus Labs Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Laurus Labs Ltd. The current rsi is 45.33. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Laurus Labs Ltd Daily Relative Strength Index (RSI) ChartLaurus Labs Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Laurus Labs Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Laurus Labs Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Laurus Labs Ltd Daily Stochastic Oscillator ChartLaurus Labs Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Laurus Labs Ltd. The current cci is -70.87554269.

Laurus Labs Ltd Daily Commodity Channel Index (CCI) ChartLaurus Labs Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Laurus Labs Ltd. The current cmo is -11.79481737.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Laurus Labs Ltd Daily Chande Momentum Oscillator (CMO) ChartLaurus Labs Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Laurus Labs Ltd. The current willr is -63.86321627.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Laurus Labs Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Laurus Labs Ltd Daily Williams %R ChartLaurus Labs Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Laurus Labs Ltd.

Laurus Labs Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Laurus Labs Ltd. The current atr is 11.87.

Laurus Labs Ltd Daily Average True Range (ATR) ChartLaurus Labs Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Laurus Labs Ltd. The current obv is -2,460,452.

Laurus Labs Ltd Daily On-Balance Volume (OBV) ChartLaurus Labs Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Laurus Labs Ltd. The current mfi is 29.54.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Laurus Labs Ltd Daily Money Flow Index (MFI) ChartLaurus Labs Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Laurus Labs Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Laurus Labs Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Laurus Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.329
Ma 20Greater thanMa 50402.063
Ma 50Greater thanMa 100398.263
Ma 100Greater thanMa 200396.302
OpenGreater thanClose392.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Laurus Labs Ltd with someone you think should read this too:
  • Are you bullish or bearish on Laurus Labs Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Laurus Labs Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Laurus Labs Ltd

I send you an email if I find something interesting about Laurus Labs Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Laurus Labs Ltd.

Receive notifications about Laurus Labs Ltd in your mailbox!